相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials
Anthony E. Lang et al.
MOVEMENT DISORDERS (2016)
Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease
Francesc Valldeoriola et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2016)
Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease
Daniela Calandrella et al.
NEUROLOGY (2015)
Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes
Angelo Antonini et al.
PARKINSONISM & RELATED DISORDERS (2015)
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
Hubert H. Fernandez et al.
MOVEMENT DISORDERS (2015)
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
Pablo Martinez-Martin et al.
MOVEMENT DISORDERS (2015)
Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients
John T. Slevin et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience
M. Zibetti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients
Mariachiara Sensi et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Long-term levodopa/carbidopa intestinal gel in advanced Parkinson's disease
Maria T. Caceres-Redondo et al.
JOURNAL OF NEUROLOGY (2014)
for the LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (vol 13, pg 141, 2014)
C. W. Olen et al.
LANCET NEUROLOGY (2014)
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow et al.
LANCET NEUROLOGY (2014)
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care
A. Antonini et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Treatment of Parkinson's disease in the advanced stage
C. Ossig et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review
Jens Volkmann et al.
JOURNAL OF NEUROLOGY (2013)
Advanced Parkinson's disease: Clinical characteristics and treatment. Part II
J. Kulisevsky et al.
NEUROLOGIA (2013)
Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)
J. Kuisevsky et al.
NEUROLOGIA (2013)
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
Hubert H. Fernandez et al.
PARKINSONISM & RELATED DISORDERS (2013)
Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease: Motor and Nonmotor Effects
Prashanth Reddy et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease
D. Nyholm et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Duodopa® treatment for advanced Parkinson's disease: A review of efficacy and safety
Dag Nyholm
PARKINSONISM & RELATED DISORDERS (2012)
Milestones in Parkinson's Disease Therapeutics
Olivier Rascol et al.
MOVEMENT DISORDERS (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2011)
Parkinson's disease: The non-motor issues
K. Ray Chaudhuri et al.
PARKINSONISM & RELATED DISORDERS (2011)
Experience with continuous levodopa enteral infusion (Duodopa®) in patients with advanced Parkinson's disease in a secondary level hospital
D. Santos-Garcia et al.
NEUROLOGIA (2010)
Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management
Angelo Antonini et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Progression of Parkinson's disease in the clinical phase: potential markers
Walter Maetzler et al.
LANCET NEUROLOGY (2009)
Intrajejunal Levodopa Infusion in Parkinson's Disease: A Pilot Multicenter Study of Effects on Nonmotor Symptoms and Quality of Life
Holger Honig et al.
MOVEMENT DISORDERS (2009)
Patient Profile, Indications, Efficacy and Safety of Duodenal Levodopa Infusion in Advanced Parkinson's Disease
David Devos
MOVEMENT DISORDERS (2009)
Continuous dopaminergic stimulation - From theory to clinical practice
Angelo Antonini
PARKINSONISM & RELATED DISORDERS (2007)
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
Bhomraj Thanvi et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease - A clinical and pharmacokinetic study
F Stocchi et al.
ARCHIVES OF NEUROLOGY (2005)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
